ArticlemSphere2018
Evolution and Comparative Genomics of F33:A-:B- Plasmids Carrying
Article in mSphere, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed.
- Emerging Dissemination of blaMicrobiologyOpen · 2026Article
- Mechanisms of fosfomycin resistance observed in clinical isolates ofJAC-antimicrobial resistance · 2026Article
- Comparative genomic study of blaScientific reports · 2025Article
- Article
- Clonal overlap and resistance profiles of multidrug-resistantVeterinary world · 2025Article
- Article
- High prevalence of plasmid-mediated Fosfomycin resistance in waterfowl-derivedFrontiers in veterinary science · 2025Article
- Unveiling the genetic architecture and transmission dynamics of a novel multidrug-resistant plasmid harboring blaBMC microbiology · 2024Article
- Current epidemiologic features and health dynamics of ESBL-producingBiosafety and health · 2024Review
- Tn3-like structures co-harboring of blaBMC veterinary research · 2023Article
- Multidrug-ResistantMicroorganisms · 2023Article
- F18:A-:B1 Plasmids CarryingAntibiotics (Basel, Switzerland) · 2023Article
- Emergence of a Hybrid IncI1-Iα Plasmid-EncodedMicroorganisms · 2023Article
- Prevalence of Antimicrobial Resistance and Clonal Relationship in ESBL/AmpC-ProducingAntibiotics (Basel, Switzerland) · 2023Article
- Antimicrobial Resistance and Increased Virulence ofMicroorganisms · 2022Article
- Identification of a Novel IncHI1B Plasmid in MDRAntibiotics (Basel, Switzerland) · 2022Article
- Phylogenomic Analysis of Salmonella enterica Serovar Indiana ST17, an Emerging Multidrug-Resistant Clone in China.Microbiology spectrum · 2022Article
- Outer Membrane Vesicles ofPathogens (Basel, Switzerland) · 2022Article
- Spreading Advantages of Coresident PlasmidsMicrobiology spectrum · 2022Article
- Molecular characterization of extended spectrum cephalosporin resistantFrontiers in microbiology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To understand the underlying evolution process of F33:A-:B- plasmids among
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.